PULMONARY LANGERHANS CELL HISTIOCYTOSIS IN A YOUNG ADULT SMOKER: A CASE REPORT
Keywords:
Cystic lung disease, High-resolution computed tomography, Pulmonary Langerhans Cell Histiocytosis, Smoking, Young adult smokerAbstract
Introduction
Pulmonary Langerhans Cell Histiocytosis (PLCH) remains a rare and enigmatic disorder among interstitial lung diseases, primarily targeting young adult smoker. It becomes a diagnostic challenge due to its variable clinical manifestations and radiological features.
Case Presentation
A 27-year-old male with a significant smoking history presented with progressive dyspnea and pleuritic chest pain. High-resolution computed tomography (HRCT) of the chest revealed classic findings of multiple nodules, cavitary lesions, and cysts with upper and mid-lung predominance, complicated by a spontaneous pneumothorax. A diagnosis of PLCH was made based on the clinical and radiological characteristics. The patient was treated with emergent chest tube insertion. Afterward, he also received a nine-day course of high-dose systemic corticosteroids and broad-spectrum antibiotics. Following stabilization of his acute condition and completion of these interventions, rigorous implementation of smoking cessation counseling was performed. Follow-up at eight months revealed significant symptomatic relief and notable radiological regression of lesions on HRCT
Conclusions
This case underscores the pivotal role of HRCT in the non-invasive diagnosis of PLCH in order to determine the acute management strategies required for life-threatening complications and reaffirms smoking cessation as the most potent long-term therapeutic intervention.
References
Sconocchia T, et al. Langerhans cell histiocytosis: current advances in molecular pathogenesis. Front Immunol. 2023;14:1275085.
Jouenne F, et al. Pulmonary Langerhans cell histiocytosis: an update on pathogenesis and treatment. Curr Opin Pulm Med. 2023;29(5):451-458.
Sencan I, Ozkan F, Sonmezer MC, Demir A, Ozdemir C, Ulasli SS, Ozdemir T, Yildiz F, Ulasli AM. Is pulmonary Langerhans cell histiocytosis really rare?: a retrospective cohort study. Eur J Radiol. 2025;170:111456.
Chang L, et al. High resolution chest computed tomography responses for a cohort of adults with pulmonary Langerhans cell histiocytosis. Clin Radiol. 2025;80(2):103780.
Hirunpat B, et al. Pulmonary Langerhans cell histiocytosis in a young adult with a history of vaping and smoking: a case report. ASEAN J Radiol. 2025;26(1):34-44.
Sakurai A, et al. BRAF V600E–mutant diffuse pulmonary Langerhans cell histiocytosis successfully treated with dabrafenib plus trametinib: a case report. Respir Case Rep. 2025;13(9):e70339.
Wu K, et al. Pulmonary BRAF-driven Langerhans cell histiocytosis following selpercatinib use in metastatic medullary thyroid cancer. Endocr Diabetes Metab Case Rep. 2024;2024(2):EDM23-0079.
Goyal G, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022;139(17):2601-2621.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Vininta Fazharyasti, Christian Hasudungan Nainggolan, Lidia Giritri Bangun, Terawan Agus Putranto (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
